Ongoing phase 2/3 trials of psychotropic drugs: is help finally on the way?
作者信息
Thase Michael E
机构信息
Perelman School of Medicine, University of Pennsylvania, Corporal M.J. Crescenz Veterans Affairs Medical Center, Philadelphia, PA, USA.
出版信息
World Psychiatry. 2023 Feb;22(1):80-82. doi: 10.1002/wps.21064.
Abstract
摘要
相似文献
1
Ongoing phase 2/3 trials of psychotropic drugs: is help finally on the way?正在进行的精神药物2/3期试验：帮助终于要来了吗？
World Psychiatry. 2023 Feb;22(1):80-82. doi: 10.1002/wps.21064.
2
Psychotropic drugs and paediatrics: a critical need for more clinical trials.精神药物与儿科：更需临床试验。
J Med Ethics. 2012 Apr;38(4):250-2. doi: 10.1136/medethics-2011-100003. Epub 2011 Nov 2.
3
[Psychotropic drugs and behavior].[精神药物与行为]
Bull Acad Natl Med. 1997 Jun-Jul;181(6):1089-101; discussion 1101-4.
4
[Psychotropic drugs and behavior].[精神药物与行为]
Ann Pharm Fr. 1998;56(2):75-82.
5
Concomitant use of anti-dementia drugs with psychotropic drugs in Norway--a population-based study.挪威抗痴呆药物与精神药物同时使用的情况——一项基于人群的研究。
Pharmacoepidemiol Drug Saf. 2011 Dec;20(12):1319-26. doi: 10.1002/pds.2211. Epub 2011 Jul 29.
6
[Prescription of psychotropic drugs in paediatry: approved indications and therapeutic perspectives].[儿科精神药物处方：批准的适应症和治疗前景]
Encephale. 2005 Jul-Aug;31(4 Pt 1):477-89. doi: 10.1016/s0013-7006(05)82409-1.
7
Psychotropic drugs for the management of cancer-related fatigue: a systematic review and meta-analysis.用于管理癌症相关疲劳的精神药物：一项系统评价和荟萃分析。
Eur J Cancer Care (Engl). 2016 Nov;25(6):970-979. doi: 10.1111/ecc.12397. Epub 2015 Oct 21.
8
Pharmacogenetics of psychotropic drug response.精神药物反应的药物遗传学
Am J Psychiatry. 2004 May;161(5):780-96. doi: 10.1176/appi.ajp.161.5.780.
9
Rapid ultraviolet monitoring of multiple psychotropic drugs with a renewable microfluidic device.利用可再生微流控装置实现多种精神药物的快速紫外监测。
Anal Chim Acta. 2010 Oct 29;679(1-2):1-6. doi: 10.1016/j.aca.2010.08.019. Epub 2010 Aug 21.
10
A systematic review on the impact of psychotropic drugs on electroencephalogram waveforms in psychiatry.关于精神药物对精神病学中脑电图波形影响的系统评价。
Postgrad Med. 2016 Sep;128(7):656-64. doi: 10.1080/00325481.2016.1218261. Epub 2016 Aug 8.
引用本文的文献
1
Combination of Two Long-Acting Antipsychotics in Schizophrenia Spectrum Disorders: A Systematic Review.两种长效抗精神病药物联合用于精神分裂症谱系障碍：一项系统评价
Brain Sci. 2024 Apr 26;14(5):433. doi: 10.3390/brainsci14050433.
本文引用的文献
1
The future of psychopharmacology: a critical appraisal of ongoing phase 2/3 trials, and of some current trends aiming to de-risk trial programmes of novel agents.精神药理学的未来：对正在进行的2/3期试验以及旨在降低新型药物试验项目风险的一些当前趋势的批判性评估。
World Psychiatry. 2023 Feb;22(1):48-74. doi: 10.1002/wps.21056.
2
Effect of AXS-05 (Dextromethorphan-Bupropion) in Major Depressive Disorder: A Randomized Double-Blind Controlled Trial.AXS-05（右美沙芬-安非他酮）治疗重性抑郁障碍的疗效：一项随机、双盲对照试验。
Am J Psychiatry. 2022 Jul;179(7):490-499. doi: 10.1176/appi.ajp.21080800. Epub 2022 May 18.
3
REL-1017 (Esmethadone) as Adjunctive Treatment in Patients With Major Depressive Disorder: A Phase 2a Randomized Double-Blind Trial.REL-1017（埃索美拉唑）作为伴发治疗在有主要抑郁混乱的病人：一个阶段 2a 被随机化的双盲的审讯。
Am J Psychiatry. 2022 Feb;179(2):122-131. doi: 10.1176/appi.ajp.2021.21020197. Epub 2021 Dec 22.
4
Muscarinic Cholinergic Receptor Agonist and Peripheral Antagonist for Schizophrenia.精神分裂症的毒蕈碱型乙酰胆碱受体激动剂和外周拮抗剂。
N Engl J Med. 2021 Feb 25;384(8):717-726. doi: 10.1056/NEJMoa2017015.
5
Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial.迷幻蘑菇辅助治疗对重度抑郁症的影响：一项随机临床试验。
JAMA Psychiatry. 2021 May 1;78(5):481-489. doi: 10.1001/jamapsychiatry.2020.3285.
6
A Non-D2-Receptor-Binding Drug for the Treatment of Schizophrenia.一种用于治疗精神分裂症的非 D2 受体结合药物。
N Engl J Med. 2020 Apr 16;382(16):1497-1506. doi: 10.1056/NEJMoa1911772.
7
Trial of SAGE-217 in Patients with Major Depressive Disorder.SAGE-217 治疗重度抑郁症患者的试验。
N Engl J Med. 2019 Sep 5;381(10):903-911. doi: 10.1056/NEJMoa1815981.
8
New medications for treatment-resistant depression: a brief review of recent developments.治疗抵抗性抑郁症的新药物：近期进展简述。
CNS Spectr. 2017 Dec;22(S1):39-48. doi: 10.1017/S1092852917000876.
Zotero 插件